The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity
Open accessAbstract
Bile secretion is essential for whole body sterol homeostasis. Loss-of-function mutations in specific canalicular transporters in the hepatocyte disrupt bile flow and result in cholestasis. We show that two of these transporters, ABCB11 and ATP8B1, are functional targets of miR-33, a micro-RNA that is expressed from within an intron of SREBP-2. Consequently, manipulation of miR-33 levels in vivo with adenovirus or with antisense oligonucleotides results in changes in bile secretion and bile recovery from the gallbladder. Using radiolabelled cholesterol, we show that systemic silencing of miR-33 leads to increased sterols in bile and enhanced reverse cholesterol transport in vivo. Finally, we report that simvastatin causes, in a dose-dependent manner, profound hepatotoxicity and lethality in mice fed a lithogenic diet. These latter results are reminiscent of the recurrent cholestasis found in some patients prescribed statins. Importantly, pretreatment of mice with anti-miR-33 oligonucleotides rescues the hepatotoxic phenotype. Therefore, we conclude that miR-33 mediates some of the undesired, hepatotoxic effects of statins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the miR-33 family prevents lipid depletion in the liver by targeting genes regulating bile acid synthesis and secretion [ATP-binding cassette subfamily B member 11 (ABCB11), amino phospholipid transporter class I type 8B member 1 (ATP8B1), and cytochrome P450 family 7, subfamily A, polypeptide 1 (CYP7A1) (Allen et al., 2012; Li et al., 2013)].”
From Genetic dissection of the impact of miR-33a and miR-33b during the progression of atherosclerosis (2017) · cites this paper as Allen et al., 2012
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
Rayner, K. J., Suárez, Y., Dávalos, A., Parathath, S., Fitzgerald, M. L., Tamehiro, N., Fisher, E. A., Moore, K. J., & Fernández-Hernando, C. (2010) · Science · doi:10.1126/science.1189862 · Cited by 1,260
Han, X., & Gross, R. W. (2004) · Mass Spectrometry Reviews · doi:10.1002/mas.20023 · Cited by 1,126
MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis
Najafi-Shoushtari, S. H., Kristo, F., Li, Y., Shioda, T., Cohen, D. E., Gerszten, R. E., & Näär, A. M. (2010) · Science · doi:10.1126/science.1189123 · Cited by 957 · cited 5×
“…that combines statins and anti-miR-33 oligonucleotides may be useful in hyperlipidemic patients by reversing statin-induced, miR-33-mediated repression of ABCA1, which ultimately would increase plasma HDL (Horie et al, 2010; Marquart et al, 2010; Najafi-Shoushtari et al, 2010; Rayner et al, 2010).”
InfluentialDisruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion
Yu, L., Hammer, R. E., Li-Hawkins, J., von Bergmann, K., Lütjohann, D., Cohen, J. C., & Hobbs, H. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252582399 · Cited by 722
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
Rayner, K. J., Esau, C. C., Hussain, F. N., McDaniel, A. L., Marshall, S. M., van Gils, J. M., Ray, T. D., Sheedy, F. J., Goedeke, L., Liu, X., et al. (2011) · Nature · doi:10.1038/nature10486 · Cited by 706
Rayner, K. J., Sheedy, F. J., Esau, C. C., Hussain, F. N., Temel, R. E., Parathath, S., van Gils, J. M., Rayner, A. J., Chang, A. N., Suarez, Y., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57275 · Cited by 690 · cited 2×
“Manipulation of miR-33 levels in vivo results in changes in circulating levels of high-density lipoproteins (HDL) (Horie et al, 2010; Marquart et al, 2010; Najafi-Shoushtari et al, 2010; Rayner et al, 2010, 2011a,b).”
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling
Dávalos, A., Goedeke, L., Smibert, P., Ramírez, C. M., Warrier, N. P., Andreo, U., Cirera-Salinas, D., Rayner, K., Suresh, U., Pastor-Pareja, J. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102281108 · Cited by 670
The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis
Rader, D. J., Alexander, E. T., Weibel, G. L., Billheimer, J. T., & Rothblat, G. H. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800088-jlr200 · Cited by 597
Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo
Wang, X., Collins, H. L., Ranalletta, M., Fuki, I. V., Billheimer, J. T., Rothblat, G. H., Tall, A. R., & Rader, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32057 · Cited by 593
Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice
Horton, J. D., Bashmakov, Y., Shimomura, I., & Shimano, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5987 · Cited by 577
Hentze, M. W., Caughman, S. W., Rouault, T. A., Barriocanal, J. G., Dancis, A., Harford, J. B., & Klausner, R. D. (1987) · Science · doi:10.1126/science.3685996 · Cited by 571
miR-33 links SREBP-2 induction to repression of sterol transporters
Marquart, T. J., Allen, R. M., Ory, D. S., & Baldán, Á. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005191107 · Cited by 562
Self-citationMouse Models for Atherosclerosis and Pharmaceutical Modifiers
Zadelaar, S., Kleemann, R., Verschuren, L., der Weij, J. D. V.-V., van der Hoorn, J., Princen, H. M. G., & Kooistra, T. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.142570 · Cited by 526
Horie, T., Ono, K., Horiguchi, M., Nishi, H., Nakamura, T., Nagao, K., Kinoshita, M., Kuwabara, Y., Marusawa, H., Iwanaga, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008499107 · Cited by 384
Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation*
Gerin, I., Clerbaux, L.-A., Haumont, O., Lanthier, N., Das, A. K., Burant, C. F., Leclercq, I. A., MacDougald, O. A., & Bommer, G. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.152090 · Cited by 382 · cited 2×
“We (Marquart et al, 2010) and others (Gerin et al, 2010; Horie et al, 2010; Najafi-Shoushtari et al, 2010; Rayner et al, 2010) recently showed that the evolutionarily conserved miR-33 is expressed from within intron 16 of SREBP-2 , and that this miRNA downregulates the expression of the sterol…”
Han, X., & Gross, R. W. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5178 · Cited by 358
Similarity of Synthetic Peptide from Human Tumor to Parathyroid Hormone in Vivo and in Vitro
Horiuchi, N., Caulfield, M. P., Fisher, J. E., Goldman, M. E., McKee, R. L., Reagan, J. E., Levy, J. J., Nutt, R. F., Rodan, S. B., Schofield, T. L., et al. (1987) · Science · doi:10.1126/science.3685994 · Cited by 353
Prevention of cholesterol gallstone disease by FXR agonists in a mouse model
Moschetta, A., Bookout, A. L., & Mangelsdorf, D. J. (2004) · Nature Medicine · doi:10.1038/nm1138 · Cited by 326
Spraul, A., Fabrè, M., Branchereau, S., Baussan, C., Gonzales, E. M., Stieger, B., Bernard, O., & Jacquemin, E. (2010) · Hepatology · doi:10.1002/hep.23539 · Cited by 284
Paulusma, C. C., Folmer, D. E., Mok, K. S., de Waart, R. D., Hilarius, P. M., Verhoeven, A. J., & Elferink, R. P. J. O. (2007) · Hepatology · doi:10.1002/hep.21950 · Cited by 243
Esteller, A. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5641 · Cited by 235
Paulusma, C. C., Groen, A., Kunne, C., Mok, K. S., Spijkerboer, A. L., de Waart, R. D., Hoek, F. J., Vreeling‐Sindelárová, H., Hoeben, K. A., van Marle, J., et al. (2006) · Hepatology · doi:10.1002/hep.21212 · Cited by 234
FXR signaling in metabolic disease
Zhang, Y., & Edwards, P. A. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.015 · Cited by 212
Familial intrahepatic cholestasis 1: Studies of localization and function
Ujházy, P., Ortiz, D., Misra, S., Li, S., Moseley, J. B., Jones, H., & Arias, I. M. (2001) · Hepatology · doi:10.1053/jhep.2001.27663 · Cited by 196
Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice.
Khanuja, B., Cheah, Y. C., Hunt, M., Nishina, P. M., Wang, D. Q., Chen, H. W., Billheimer, J. T., Carey, M. C., & Paigen, B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7729 · Cited by 194
Self-citationExpression of ABCG5 and ABCG8 Is Required for Regulation of Biliary Cholesterol Secretion
Yu, L., Gupta, S., Xu, F., Liverman, A. D. B., Moschetta, A., Mangelsdorf, D. J., Repa, J. J., Hobbs, H. H., & Cohen, J. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411080200 · Cited by 192
Chen, F. Y., Ananthanarayanan, M., Emre, S., Neimark, E., Bull, L. N., Knisely, A. S., Strautnieks, S. S., Thompson, R. J., Magid, M. S., Gordon, R. D., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.013 · Cited by 191
Self-citationMutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia
Hubacek, J. A., Berge, K. E., Cohen, J. C., & Hobbs, H. H. (2001) · Human Mutation · doi:10.1002/humu.1206 · Cited by 166
Lammert, F., Wang, D. Q. ‐., Hillebrandt, S., Geier, A., Fickert, P., Trauner, M. A., Matern, S., Paigen, B. J., & Carey, M. C. (2004) · Hepatology · doi:10.1002/hep.20022 · Cited by 157
Self-citationBile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease
Gadaleta, R. M., van Mil, S. W. C., Oldenburg, B., Siersema, P. D., Klomp, L. W. J., & van Erpecum, K. J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.04.006 · Cited by 147
Partial external biliary diversion for intractable pruritus and xanthomas in Alagille syndrome
Emerick, K. M., & Whitington, P. F. (2002) · Hepatology · doi:10.1053/jhep.2002.33332 · Cited by 124
Frankenberg, T., Miloh, T., Chen, F. Y., Ananthanarayanan, M., Sun, A., Balasubramaniyan, N., Arias, I. M., Setchell, K. D. R., Suchy, F. J., & Shneider, B. L. (2008) · Hepatology · doi:10.1002/hep.22431 · Cited by 123
Self-citationSevere Cholestasis Induced by Cholic Acid Feeding in Knockout Mice of Sister of P–Glycoprotein
Wang, R., Lam, P., Liu, L., Forrest, D., Yousef, I. M., Mignault, D., Phillips, J. M., & Ling, V. W. T. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.037 · Cited by 123
Morotti, R. A., Suchy, F. J., & Magid, M. S. (2011) · Seminars in Liver Disease · doi:10.1055/s-0031-1272831 · Cited by 122
Self-citationvan der Woerd, W. L., van Mil, S. W. C., Stapelbroek, J. M., Klomp, L. W. J., van de Graaf, S. F. J., & Houwen, R. H. J. (2010) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2010.07.010 · Cited by 121
Cai, S., Gautam, S., Nguyen, T., Soroka, C. J., Rahner, C., & Boyer, J. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.025 · Cited by 119
Álvarez, L., Jara, P., Sánchez-Sabaté, E., Hierro, L., Larrauri, J., Díaz, M. C., Camarena, C., Vega, A. D. L., Frauca, E., López‐Collazo, E., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh261 · Cited by 117
Molecular regulation of macrophage reverse cholesterol transport
Wang, X., & Rader, D. J. (2007) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3281ec5113 · Cited by 112
Future Therapeutic Directions in Reverse Cholesterol Transport
Khera, A. V., & Rader, D. J. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0080-0 · Cited by 111
Biliary Sterol Secretion Is Not Required for Macrophage Reverse Cholesterol Transport
Temel, R. E., Sawyer, J. K., Yu, L., Lord, C. C., Degirolamo, C., McDaniel, A. L., Marshall, S., Wang, N., Shah, R., Rudel, L. L., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.05.011 · Cited by 110
Pawlikowska, L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh100 · Cited by 105
Stojaković, T., Putz‐Bankuti, C., Fauler, G., Scharnagl, H., Wagner, M., Stadlbauer, V., Gurakuqi, G. C., Stauber, R. E., März, W., & Trauner, M. (2007) · Hepatology · doi:10.1002/hep.21741 · Cited by 85
Bennett, M. K., Seo, Y., Datta, S., Shin, D.-J., & Osborne, T. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800391200 · Cited by 70
Biliary Sterol Secretion Is Required for Functional In Vivo Reverse Cholesterol Transport in Mice
Nijstad, N., Gautier, T., Briand, F., Rader, D. J., & Tietge, U. J. F. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.11.055 · Cited by 69
Nijstad, N., Wiersma, H., Gautier, T., van der Giet, M., Maugeais, C., & Tietge, U. J. F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807683200 · Cited by 68
Progressive familial intrahepatic cholestasis.
Hori, T., Nguyen, J. H., & Üemoto, S. (2010) · PubMed · Cited by 63
Progressive familial intrahepatic cholestasis: Genetic disorders of biliary transporters
Harris, M., Couteur, D. G. L., & Arias, I. M. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03743.x · Cited by 62
Stojaković, T., Claudel, T., Putz‐Bankuti, C., Fauler, G., Scharnagl, H., Wagner, M., Sourij, H., Stauber, R. E., Winkler, K., März, W., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.08.052 · Cited by 59
Aquaporins in the hepatobiliary tract. Which, where and what they do in health and disease
Portincasa, P., Palasciano, G., Svelto, M., & Calamita, G. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01897.x · Cited by 52
Liver transplantation in children with Alagille syndrome: Indications and outcome
Englert, C., Grabhorn, E. F., Burdelski, M. M., & Ganschow, R. (2006) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2005.00432.x · Cited by 51
Ford, D. A., Monda, J. K., Brush, R. S., Anderson, R. E., Richards, M. J., & Fliesler, S. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05203.x · Cited by 49
Self-citationHepatic SR-BI, not endothelial lipase, expression determines biliary cholesterol secretion in mice
Wiersma, H., Gatti, A., Nijstad, N., Kuipers, F., & Tietge, U. J. F. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800434-jlr200 · Cited by 47
Progressive familial intrahepatic cholestasis.
Cavestro, G. M., Frulloni, L., Cerati, E., Ribeiro, L. A., Corrente, V., Sianesi, M., Franzè, A., & Mario, F. D. (2002) · PubMed · Cited by 46
Wang, J., Huff, E., Janecka, L., & Hegele, R. A. (2001) · Human Mutation · doi:10.1002/humu.1205 · Cited by 45
Statins in Primary Biliary Cirrhosis: Are They Safe?
Rajab, M. A., & Kaplan, M. M. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0988-9 · Cited by 35
Annema, W., Dikkers, A., de Boer, J. F., Gautier, T., Rensen, P. C. N., Rader, D. J., & Tietge, U. J. F. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m020743 · Cited by 30
Chen, F., Ellis, E. C. S., Strom, S. C., & Shneider, B. L. (2010) · Pediatric Research · doi:10.1203/pdr.0b013e3181c2df16 · Cited by 27
Martínez-Fernández, P., Hierro, L., Jara, P., & Álvarez, L. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90371.2008 · Cited by 27
Acute cholestatic hepatitis after reinitiating treatment with atorvastatin
Ridruejo, E., & Mandό, O. G. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00092-2 · Cited by 26
Tietge, U. J. F., Nijstad, N., Havinga, R., Baller, J. F. W., van der Sluijs, F. H., Bloks, V. W., Gautier, T., & Kuipers, F. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700276-jlr200 · Cited by 23
Atorvastatin Does Not Improve Liver Biochemistries or Mayo Risk Score in Primary Biliary Cirrhosis
Stanca, C. M., Bach, N., Allina, J., Bodian, C., Bodenheimer, H. C., & Odin, J. A. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0003-2 · Cited by 22
FIC1-mediated stimulation of FXR activity is decreased with PFIC1 mutations in HepG2 cells
Koh, S., Takada, T., Kukuu, I., & Suzuki, H. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0041-y · Cited by 21
Inborn Errors of Biliary Canalicular Transport Systems
Kubitz, R., Keitel, V., & Häussinger, D. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)00031-5 · Cited by 19
Cholestasis associated with the use of pravastatin sodium
Batey, R. G., & Harvey, M. A. (2002) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2002.tb04559.x · Cited by 19
Hepatitis colestásica aguda tras la reintroducción de atorvastatina
de Castro, M. L., Hermo, J. A., Lomba, A. B., de Luaces, C., Perez, R. A. T., & Clofent, J. (2006) · Gastroenterología y Hepatología · doi:10.1157/13083248 · Cited by 17
Atorvastatin-Induced Prolonged Cholestasis with Bile Duct Damage
Merli, M., Bragazzi, M. C., Giubilo, F., Callea, F., Attili, A. F., & Alvaro, D. (2010) · Clinical Drug Investigation · doi:10.2165/11531660-000000000-00000 · Cited by 16
Strain Background Modifies Phenotypes in the ATP8B1-Deficient Mouse
Shah, S., Sanford, U. R., Vargas, J. C., Xu, H., Groen, A. K., Paulusma, C. C., Grenert, J. P., Pawlikowska, L., Sen, Ś., Elferink, R. P. J. O., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008984 · Cited by 16
Rahier, J. F., Rahier, J., Leclercq, I., & Geubel, A. P. (2008) · PubMed · Cited by 15
Hepatitis aguda colestásica por cerivastatina
Torres, M., Sobrino, J., Asensio, C., & López, D. (2002) · Medicina Clínica · doi:10.1016/s0025-7753(02)72507-4 · Cited by 5
Cited by
Sorted by citations
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935
MicroRNA Regulation of Atherosclerosis
Feinberg, M. W., & Moore, K. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.306300 · Cited by 638
MicroRNA-mediated regulation of glucose and lipid metabolism
Agbu, P., & Carthew, R. W. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00354-w · Cited by 376
MicroRNAs in Metabolic Disease
Fernández-Hernando, C., Ramírez, C. M., Goedeke, L., & Suárez, Y. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300144 · Cited by 257
MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice
Horie, T., Nishino, T., Baba, O., Kuwabara, Y., Nakao, T., Nishiga, M., Usami, S., Izuhara, M., Sowa, N., Yahagi, N., et al. (2013) · Nature Communications · doi:10.1038/ncomms3883 · Cited by 230
Metadata
- Authors
- Allen, R. M., Marquart, T. J., Albert, C. J., Suchy, F. J., Wang, D. Q. ‐., Ananthanarayanan, M., Ford, D. A., & Baldán, Á.
- Affiliations
- Saint Louis University (US)
- University of Colorado Anschutz (US)
- Yale University (US)
- Corresponding author
- Baldán, Ángel
- Venue
- EMBO Molecular Medicine
- Published
- 2012-07-05
- Volume
- 4
- Issue
- 9
- Pages
- 882-895
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC3491822
- OpenAlex
- W2159167853
- Cited by
- 159
- References
- 70
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 13 · 2020: 9 · 2019: 10 · 2018: 15 · 2017: 12 · 2016: 16 · 2015: 19 · 2014: 24 · 2013: 18 · 2012: 3
- FWCI
- 20.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- EMBO Molecular Medicine (publishedVersion, other-oa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- AHA (11SDG5030012)
- NIH (HL107794 (to Á.B.), HL074214, HL098907, RR019232)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Keywords
- miR-33, ABCB11, ATP8B1, simvastatin, lithogenic diet, cholestasis, bile secretion, sterol homeostasis, reverse cholesterol transport, SREBP2, antisense oligonucleotides, gallbladder
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily B, Member 11, Adenosine Triphosphatases, Animals, Bile, Cells, Cultured, Diet, Gene Expression Regulation, Liver, Male, Mice, Inbred C57BL, Models, Biological, ATP-Binding Cassette Transporters, Simvastatin, Hepatocytes, MicroRNAs, Phospholipid Transfer Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review